PRINCETON, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...
pending the expected receipt of Medical Device Single Audit Program (MDSAP) certification in the near futureExpecting FDA and Health Canada decisions in 2025 PRINCETON, N.J., Oct. 01, 2024 (GLOBE ...
BusinessWire India New Delhi [India] October 19 Auxein a global innovator in orthopaedic and arthroscopy solutions is proud ...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health ...
Oct. 16, 2024 — Before the FDA allows prescription medicines on the market, drugmakers must prove they’re safe and effective. What’s less widely known is that most medical devices ...
To comply with the 21st Century Cures Act, 1 the Food and Drug Administration (FDA) has released two Notices of Proposed Rulemaking (NPRMs). NPRMs are the initial public notice of a proposed ...
A wearable technology is the latest addition to the treatment mix. The FDA has approved a Novocure medical device that uses fields of electricity to kill cancer cells. The regulatory decision anno ...
UCB, a global biopharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved a 2 mL pre-filled syringe and pre-filled autoinjector, each containing 320 mg of Bimzelx ...
Auxein, an innovator in orthopaedic solutions, becomes the first Asian company to achieve EU-MDR certification for its trauma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback